Unicycive Therapeutics, Inc. (UNCY)
NASDAQ: UNCY · Real-Time Price · USD
0.6814
+0.0435 (6.82%)
At close: Jun 13, 2025, 4:00 PM
0.6700
-0.0114 (-1.67%)
After-hours: Jun 13, 2025, 5:18 PM EDT
Unicycive Therapeutics Stock Forecast
Stock Price Forecast
According to 4 professional analysts, the 12-month price target for Unicycive Therapeutics stock ranges from a low of $3.00 to a high of $9.00. The average analyst price target of $6.38 forecasts a 836.31% increase in the stock price over the next year.
Price Target: $6.38 (+836.31%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Unicycive Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $9 | Strong Buy | Initiates | $9 | +1,220.81% | May 27, 2025 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +780.54% | Apr 21, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $7.5 | Strong Buy | Reiterates | $7.5 | +1,000.68% | Apr 11, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $4 → $7.5 | Strong Buy | Maintains | $4 → $7.5 | +1,000.68% | Apr 1, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $4 | Strong Buy | Reiterates | $4 | +487.03% | Jan 29, 2025 |
Financial Forecast
Revenue This Year
23.70M
Revenue Next Year
369.31M
from 23.70M
Increased by 1,458.53%
EPS This Year
-0.29
from -0.56
EPS Next Year
0.88
from -0.29
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 45.7M | 629.9M | 1.2B | ||
| Avg | 23.7M | 369.3M | 733.1M | ||
| Low | 4.1M | 200.3M | 168.3M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | 2,558.4% | 223.6% | ||
| Avg | - | 1,458.5% | 98.5% | ||
| Low | - | 745.2% | -54.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 0.04 | 1.72 | 3.54 | ||
| Avg | -0.29 | 0.88 | 1.99 | ||
| Low | -0.42 | 0.43 | 0.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | 301.5% | ||
| Avg | - | - | 125.4% | ||
| Low | - | - | -70.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.